Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Prescription Drug Abuse Impacts 80% of Ind. Workplaces; Novus Medical Detox Center Advises Expanded Education
  • USA - English


News provided by

JoTo PR

Apr 11, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Kent Runyon, of Novus Medical Detox Center, comments on drug abuse impacting the workforce.
Kent Runyon, of Novus Medical Detox Center, comments on drug abuse impacting the workforce.
Youtube
Youtube

New Port Richey, FL (PRWEB) April 11, 2016 -- Recent study findings released by the National Safety Council (NSC) and Indiana Attorney General revealed 80% of Indiana employers have been impacted by prescription drug misuse and abuse (1), with one expert anticipating “very similar results in many states” (2). Novus Medical Detox Center, a leading Florida-based drug treatment facility, believes the research demonstrates a compelling need for expanded education initiatives and a greater emphasis on employee assistance programs (EAPs).

These statistics reveal the staggering economic and societal impact of prescription drug abuse, particularly opioid painkillers.

Post this

The NSC poll found 64% of Indiana employers believe that prescription drugs—including opioids such as OxyContin, Vicodin and Percocet—are a bigger problem than illegal drugs (1). Yet only 53% of employers have a written policy concerning prescription drug use at work, just 52% test for synthetic opioids and less than one-third offer training regarding workplace use of prescription drugs (1).

Other studies estimated that nonmedical use of prescription opioids costs the United States upwards of $53.4 billion per year, including $42 billion in lost productivity (3), while prescription drug diversion is estimated to cost insurers up to $72.5 billion annually (4). NSC’s Deborah Hersman asserted that workers’ compensation costs are four times higher for employees taking prescription medication, and she noted that 25% of all prescription costs in workers’ comp are opioid painkillers (2). Furthermore, government reports reveal that the rate of opioid overdose deaths tripled from 2000 to 2014, when opioid overdoses were involved in 28,647 fatalities—61% of all drug overdose deaths that year (5).

“These statistics reveal the staggering economic and societal impact of prescription drug abuse, particularly opioid painkillers,” stated Kent Runyon, Vice President of Community Relations and Chief Strategy and Compliance Officer for Novus Medical Detox Center. “Given the rampant prescription medication misuse and abuse reported by Indiana employers, and the likelihood of similarly high rates in other states, it’s clear that employers have an important role to play in addressing America’s prescription opioid epidemic.”

Runyon advises all employers to maintain a written policy regarding prescription drug use in the workplace and to provide relevant education and training to human resources (HR) staff, managers and employees. The Indiana study found that more than 60% of employers were “not confident” their HR teams, supervisors and employees could spot the warning signs of prescription drug abuse, which likely reflects the relatively low levels of training provided—only 29% of employers train their supervisors on workplace use of prescription drugs, and a mere 13% extend training to other employees (1).

“All employees need to understand how to identify potential cases of substance abuse and what they should do to ensure someone with a substance use disorder gets the necessary help,” explained Runyon. “In addition, educating employees on the negative effects prescription drug abuse can have on their career, health and personal life may help prevent drug abuse from occurring in the first place. Finally, employers should make sure all personnel are aware of the company’s employee assistance program and the confidential services it provides, and encourage them to make use of the EAP as needed.”

Novus offers medically supervised alcohol and drug treatment programs, including opioid withdrawal and detox. The Florida detox facility provides individually customized treatment plans with 24-hour access to nursing care and withdrawal specialists. Novus is recognized for its expertise in safely and comfortably treating even high-dose opioid users, including high-dose methadone cases many other facilities refuse to treat.

For more information on Novus Medical Detox Center and its prescription drug treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox is a Joint Commission Accredited inpatient medical-detox facility. Novus offers safe, effective alcohol and drug treatment programs in a peaceful, relaxed and tranquil spa-like setting. Bordering a protected conservation area, Novus lies on 3.25 acres and provides a perfect setting for quiet walks. Novus is located in New Port Richey, Florida, and is also licensed by the Florida Department of Children and Families and is known for minimizing the discomfort of withdrawal from prescription medication, drugs or alcohol by creating a customized detox program for each patient. By incorporating medication, natural supplements and fluid replenishment, Novus tailors the detox process for each patient. There is 24/7 medical supervision, including round-the-clock nursing care and access to a withdrawal specialist. Novus’ expansion is tied to their contribution to their industry and their local community, ranking in the Florida Business Journal’s top 500, the Tampa Bay Business Journal’s Fast 50 and Inc. Magazine’s 500/5000 list of fastest-growing companies in America for the past 3 years. Novus has become a regular source to the media, such as The Wall Street Journal and USA Today publications, as true advocates for standardization of care in detox in order to help more people get their lives back. For more information, visit http://www.novusdetox.com.

1. National Safety Council. “Prescription Drug Abuse Impacts 80% of Indiana Workplaces, says National Safety Council Poll”; press release issued December 7, 2015. nsc.org/Connect/NSCNewsReleases/Lists/Posts/Post.aspx?ID=87

2. Gusovsky, Dina. “America's Painkiller Epidemic Grips the Workplace”; CNBC; December 15, 2015. cnbc.com/2015/12/15/80-percent-of-workplaces-face-this-drug-scourge.html

3. Hansen, Ryan N.; Gerry Oster; et al. “Economic Costs of Nonmedical Use of Prescription Opioids”; Clinical Journal of Pain; March/April 2011. ncbi.nlm.nih.gov/pubmed/21178601

4. Coalition Against Insurance Fraud. Prescription for Peril; December 2007. insurancefraud.org/downloads/drugDiversion.pdf

5. Rudd, Rose A.; Noah Aleshire; et al. “Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014”; Morbidity and Mortality Weekly Report; January 1, 2016. cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.